Final answer:
The DOC HBV vaccination program aims to reduce HBV transmission in a health-care setting by offering vaccination to at-risk individuals, including children and health-care workers. The vaccine is a non-infectious subunit viral vaccine derived from HBsAg, produced in yeast cells. By ensuring widespread vaccination, the program can protect individuals from HBV infection and associated complications.
Step-by-step explanation:
The DOC HBV vaccination program refers to the vaccination program for Hepatitis B Virus (HBV) conducted by the Department of Correction (DOC) in a health-care setting. The program aims to reduce the transmission of HBV among individuals, especially health-care workers and inmates in correctional facilities. The vaccination is recommended for children and adults at greater risk of infection, such as intravenous drug users or those who have sex with multiple partners.
The HBV vaccine is a non-infectious subunit viral vaccine derived from HBsAg, produced in yeast cells. It is administered in two doses as part of the standard vaccination schedule, with the first dose given at birth and the second by 18 months of age. The vaccine is also offered to health-care workers who have occupational exposure to blood and/or other infectious materials.
By ensuring widespread vaccination, the DOC HBV vaccination program can protect individuals from HBV infection, reduce the transmission of the virus, and decrease the incidence of chronic infections, cirrhosis, liver failure, and liver cancer associated with HBV.